Search

Results 1-10 of 51
Publication DateTitleAuthor(s)
24-Mar-2017Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is down-regulated in metaplastic breast cancerYague, E; Asaduzzaman, M; Constantinou, S; Haoxiang, M; Gallon, J, et al
11-Jun-2014Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cellsLombardo, Y; Faronato, M; Filipovic, A; Vircillo, V; Magnani, L, et al
27-Aug-1999Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breastHarper-Wynne, C; English, J; Meyer, L; Bower, M; Archer, C, et al
24-Sep-2015APOBEC3B mediated cytidine deamination is required for estrogen receptor action in breast cancerAli, S; Periyasamy, M; Patel, H; Lai, C-F; Nguyen, VTM, et al
4-Jun-2015DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activationFaronato, M; Nguyen, VTM; Patten, DK; Lombardo, Y; Steel, JH, et al
15-Jun-2015The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.Magnani, L; Patten, DK; Nguyen, VTM; Hong, SP; Steel, JH, et al
1-May-2015Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in beta-adrenergic signaling and enhances apoptosisRoca-Alonso, L; Castellano, L; Mills, A; Dabrowska, AF; Sikkel, MB, et al
14-Jun-2016CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancerPatel, H; Abduljabbar, R; Lai, CF; Periyasamy, M; Harrod, A, et al
27-Jan-2016Spearhead Nanometric Field-Effect Transistor Sensors for Single-Cell Analysis.Zhang, Y; Clausmeyer, J; Babakinejad, B; López Córdoba, A; Ali, T, et al
10-Apr-2013miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcriptsPellegrino, L; Stebbing, J; Braga, VM; Frampton, AE; Jacob, J, et al